Jonathan I Silverberg, MD/ PhD/MPH
Sanofi Genzyme and Regeneron Pharmaceuticals Symposium
New Frontiers and Pivotal Investigation-Based Advances in the Pathoimmunobiology and Management Of Atopic Dermatitis
The Disease Burden, Quality-of-Life Impairment, and Comorbidities of AD and The Implications for Treatment for Patients with Moderate-to-Severe Disease
Jonathan Silverberg, MD/ PhD/MPH, Assistant Professor of Dermatology, Medical Social Sciences and Preventive Medicine, is a pioneer in identifying the increased cardiovascular risks associated with atopic dermatitis. As new therapies become available that counteract the systemic inflammation associated with inflammatory skin diseases, he hopes to observe the potential related reduction in cardiovascular risk.
In 2014, Dr. Silverberg founded Northwestern Medicine’s Multidisciplinary Eczema Center, and as its director, he has been able to advance research by investigating the burdens of atopic dermatitis and testing cutting-edge therapeutic approaches in addition to helping patients with eczema and their comorbidities.